Results 171 to 180 of about 276,376 (316)

Hypertrophic cardiomyopathy [PDF]

Current Problems in Cardiology, 1993
openaire   +3 more sources

Oligogenic cardiomyopathy

The Journal of Cardiovascular Aging, 2022
openaire   +3 more sources

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy

, 2005
Non ischemic dilated cardiomyopathy (NIDCM) is a disorder of myocardium. It has varying etiologies. Albeit the varying etiologies of this heart muscle disorder, it presents with symptoms of heart failure, and rarely as sudden cardiac death (SCD ...
Shekha, Karthik, Yisachar Greenberg, Karthik Shekha, Ghosh, Joydeep, Joydeep Ghosh, Greenberg, Yisachar, Deepak Thekkoott, Thekkoott, Deepak   +7 more
core  

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

The Heart of the Thymus: A Rare Tale of Nonischemic Cardiomyopathy in the Absence of Myasthenia Gravis. [PDF]

Clin Case Rep
Barman M, Al Hariri B, Babiker T, Gadkarem M, Alhariri J, Alharafsheh A.   +5 more
europepmc   +1 more source

Inherited cardiomyopathies [PDF]

BMJ, 2019
Miles, C, Fanton, Z, Tome, M, Behr, ER
openaire   +3 more sources

Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm

, 2016
A case report of apical left ventricular aneurysm in patient with hypertrophic cardiomyopathy with mid-ventricular obstruction (diagnosis and surgical treatment) is presented.
D.I. Besh, S.S. Pavlyk, Yu.H. Kyjak, V.S. Moroz, I.M. Bigun, Yu.A. Ivaniv, N.D. Oryshchyn   +6 more
core  

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Electrophysiological Markers in Hypertrophic Cardiomyopathy: Enhancing Sudden Cardiac Death Risk Prediction with Index of Cardiac Electrophysiological Balance and Its Corrected Variant. [PDF]

Anatol J Cardiol
Balaban İ, Tanyeri S, Karaduman A, Kültürsay B, Gültekin Güner E, Keten MF, Efe SÇ, Alizade E.   +7 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source